Recent changes to the classification of GPA have included PR3-ANCA [21], and previous studies have suggested clinical outcomes and genetic susceptibility are better predicted by ANCA status rather than GPA or MPA disease type [22, 23]. The gene discussed is PRTN3; the disease is microscopic polyangiitis.